Vivos: Non-Surgical Solution for Obstructive Sleep Apnea | VVOS
Clinical studies with Vivos devices have shown that 12.5–25% of patients may continue wearing a CPAP device. All content found on the vivos.com website—including text, images, audio, or other …
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral ...
Nov 29, 2023 · The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities …
Vivos | Obstructive Sleep Apnea Patients
Based on your specific needs, your Vivos-trained dentist will conduct a comprehensive evaluation, taking all relevant clinical records, in order to formulate a customized treatment plan.
Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA ...
Jan 4, 2023 · Vivos believes its patented appliances and related proprietary protocols offer significant advantages over existing OSA treatments. “This clearance is the culmination of years of pioneering …
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full ...
Apr 8, 2024 · The three Vivos CARE devices open airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA, such as lowering Apnea Hypopnea Index …
Expand Your Practice: Become a Vivos Provider
The Vivos Method is a multidisciplinary treatment protocol that uses cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial …
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest …
Apr 16, 2025 · Vivos has agreed to pay up to $9 million for the SCN operating assets, including $6 million in cash and $1.5 million in Vivos common stock at closing. An additional $1.5 million in Vivos …
Vivos News & Events
Looking for a treatment for obstructive sleep apnea? We're here to help with more information. Vivos Latest News & Events
Find a Vivos Provider with our Locator - Vivos.com
View here and know where the nearest provider you can go and contact to! View many providers of Vivos now! Click here!
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine
Oct 11, 2023 · The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA in adults.